Relationship of serum bilirubin to toxicity in patients with metastatic colorectal cancer treated with single-agent high-dose irinotecan.
Kramar
Andrew
A
Gourgou-Bourgade
Sophie
S
Ychou
Marc
M
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000627:therapeutic use; D001663:Bilirubin / Q000097:blood*; D002166:Camptothecin / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D004334:Drug Administration Schedule; D006801:Humans; D000077146:Irinotecan; D008991:Monitoring, Physiologic; D009503:Neutropenia / Q000139:chemically induced; D015203:Reproducibility of Results
D000972:Antineoplastic Agents, Phytogenic; D000077146:Irinotecan; D001663:Bilirubin; D002166:Camptothecin